Download | < Back |
30 Apr 2022 | |
Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed a copy of the Monitoring agency report of the Company for the quarter ended 31 March 2022, issued by ICICI Bank Limited, appointed to monitor the utilization of proceeds of an Initial Public Offering ('IPO') of the Company. The above information is also being made available on the website of the Company at www.tatvachintan.com. Kindly take the above information on your record. | |
View all announcements for Tatva Chintan Pharma Chem Ltd | Source: BSE India |